MYCN and medulloblastoma: Here, we highlighted a higher CHK1 expression in MNA compared to non-MNA human neuroblastoma, and in SHH-type medulloblastomas compared to normal cerebella, consistent with an increased efficacy of CHK1i in MNA and in MYCN-OE.